Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaboration Brings Continuous Monitoring to Metabolic Care Management

By HospiMedica International staff writers
Posted on 16 Apr 2026

Metabolic conditions require long-term management, yet clinicians often lack visibility into daily fluctuations that shape outcomes. More...

Limited, episodic data can delay risk recognition and constrain timely adjustments to therapy and coaching. A new system now offers continuous, personalized metabolic care by pairing real-time wearable-derived signals with clinician-led programs.

Vida Health and ŌURA have integrated biometric data from the Oura Ring into Vida’s value-based virtual cardiometabolic care programs to deliver a continuous, personalized model of metabolic care. The collaboration is designed to provide actionable insights that drive lasting behavior change, measurable outcomes, and a data-driven approach for employers and health plans to improve workforce health and manage costs. Care teams can monitor member status between appointments, laboratory testing, and coaching sessions to support earlier, more informed decisions.

Through the integration, clinicians gain access to key physiological signals—including sleep, heart rate variability (HRV), and resting heart rate—combined with clinical and behavioral data to create a comprehensive view of member health. This enables earlier identification of potential risks and supports more precise care decisions between contacts, which the companies note can improve engagement and adherence. The approach reflects a broader shift toward continuous, data‑informed healthcare in which wearable technology extends care beyond episodic treatment.

Vida plans to use ŌURA’s insights to refine and optimize care by adjusting plans based on changes in recovery or cardiovascular signals, personalizing coaching according to sleep and stress patterns, and identifying early warning signals before additional clinical intervention is required. For employers and health plans, the model offers an evidence‑based pathway to improved outcomes and potential cost savings. 

“Providers are often making decisions based on limited snapshots, such as on an office visit, lab result, or a patient’s recollection,” said Richard Frank, MD, Chief Medical Officer at Vida Health. “What’s been missing is a continuous view of how patients are actually doing day to day. By incorporating real-time insights from ŌURA with our clinical expertise and whole-person care model, we can personalize support, intervene earlier, and help members make incremental changes that add up to meaningful results over time.”

Related Links
Vida Health
ŌURA


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.